IBDEI09C ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12485,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,12486,0)
 ;;=286.59^^77^777^7
 ;;^UTILITY(U,$J,358.3,12486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12486,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,12486,1,4,0)
 ;;=4^HEMOR D/O DUE TO CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,12486,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,12487,0)
 ;;=268.9^^77^777^12
 ;;^UTILITY(U,$J,358.3,12487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12487,1,3,0)
 ;;=3^268.9
 ;;^UTILITY(U,$J,358.3,12487,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,12487,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,12488,0)
 ;;=790.29^^77^777^8
 ;;^UTILITY(U,$J,358.3,12488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12488,1,3,0)
 ;;=3^790.29
 ;;^UTILITY(U,$J,358.3,12488,1,4,0)
 ;;=4^HYPERGLYCEMIA
 ;;^UTILITY(U,$J,358.3,12488,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,12489,0)
 ;;=389.9^^77^778^7
 ;;^UTILITY(U,$J,358.3,12489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12489,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,12489,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,12489,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,12490,0)
 ;;=380.4^^77^778^8
 ;;^UTILITY(U,$J,358.3,12490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12490,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,12490,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,12490,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,12491,0)
 ;;=382.9^^77^778^9
 ;;^UTILITY(U,$J,358.3,12491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12491,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,12491,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,12491,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,12492,0)
 ;;=365.11^^77^778^5
 ;;^UTILITY(U,$J,358.3,12492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12492,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,12492,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,12492,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,12493,0)
 ;;=372.72^^77^778^10
 ;;^UTILITY(U,$J,358.3,12493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12493,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,12493,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,12493,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,12494,0)
 ;;=365.70^^77^778^1
 ;;^UTILITY(U,$J,358.3,12494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12494,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,12494,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,12494,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,12495,0)
 ;;=365.71^^77^778^3
 ;;^UTILITY(U,$J,358.3,12495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12495,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,12495,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
 ;;^UTILITY(U,$J,358.3,12495,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,12496,0)
 ;;=365.72^^77^778^4
 ;;^UTILITY(U,$J,358.3,12496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12496,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,12496,1,4,0)
 ;;=4^GLAUCOMA,MODERATE STAGE
 ;;^UTILITY(U,$J,358.3,12496,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,12497,0)
 ;;=365.73^^77^778^6
 ;;^UTILITY(U,$J,358.3,12497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12497,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,12497,1,4,0)
 ;;=4^GLAUCOMA,SEVERE STAGE
 ;;^UTILITY(U,$J,358.3,12497,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,12498,0)
 ;;=365.74^^77^778^2
 ;;^UTILITY(U,$J,358.3,12498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12498,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,12498,1,4,0)
 ;;=4^GLAUCOMA,INDETERM STAGE
 ;;^UTILITY(U,$J,358.3,12498,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,12499,0)
 ;;=571.5^^77^779^1
 ;;^UTILITY(U,$J,358.3,12499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12499,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,12499,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER
 ;;^UTILITY(U,$J,358.3,12499,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,12500,0)
 ;;=530.81^^77^779^2
 ;;^UTILITY(U,$J,358.3,12500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12500,1,3,0)
 ;;=3^530.81
 ;;^UTILITY(U,$J,358.3,12500,1,4,0)
 ;;=4^ESOPHAGEAL REFLUX (GERD)
 ;;^UTILITY(U,$J,358.3,12500,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,12501,0)
 ;;=558.9^^77^779^4
 ;;^UTILITY(U,$J,358.3,12501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12501,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,12501,1,4,0)
 ;;=4^GASTROENTERITIS/COLITIS, NONINFECT
 ;;^UTILITY(U,$J,358.3,12501,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,12502,0)
 ;;=564.1^^77^779^8
 ;;^UTILITY(U,$J,358.3,12502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12502,1,3,0)
 ;;=3^564.1
 ;;^UTILITY(U,$J,358.3,12502,1,4,0)
 ;;=4^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,12502,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,12503,0)
 ;;=211.3^^77^779^9
 ;;^UTILITY(U,$J,358.3,12503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12503,1,3,0)
 ;;=3^211.3
 ;;^UTILITY(U,$J,358.3,12503,1,4,0)
 ;;=4^POLYPS, COLON/LG BOWEL (BENIGN NEO
 ;;^UTILITY(U,$J,358.3,12503,2)
 ;;=^13295
 ;;^UTILITY(U,$J,358.3,12504,0)
 ;;=533.90^^77^779^10
 ;;^UTILITY(U,$J,358.3,12504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12504,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,12504,1,4,0)
 ;;=4^ULCER, PEPTIC
 ;;^UTILITY(U,$J,358.3,12504,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,12505,0)
 ;;=535.00^^77^779^3
 ;;^UTILITY(U,$J,358.3,12505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12505,1,3,0)
 ;;=3^535.00
 ;;^UTILITY(U,$J,358.3,12505,1,4,0)
 ;;=4^GASTRITIS, ACUTE
 ;;^UTILITY(U,$J,358.3,12505,2)
 ;;=^270169
 ;;^UTILITY(U,$J,358.3,12506,0)
 ;;=070.54^^77^779^6
 ;;^UTILITY(U,$J,358.3,12506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12506,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,12506,1,4,0)
 ;;=4^HEPATITIS C,CHRONIC,W/O COMA
 ;;^UTILITY(U,$J,358.3,12506,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,12507,0)
 ;;=553.9^^77^779^7
 ;;^UTILITY(U,$J,358.3,12507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12507,1,3,0)
 ;;=3^553.9
 ;;^UTILITY(U,$J,358.3,12507,1,4,0)
 ;;=4^HERNIA
 ;;^UTILITY(U,$J,358.3,12507,2)
 ;;=^56659
 ;;^UTILITY(U,$J,358.3,12508,0)
 ;;=455.6^^77^779^5
 ;;^UTILITY(U,$J,358.3,12508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12508,1,3,0)
 ;;=3^455.6
 ;;^UTILITY(U,$J,358.3,12508,1,4,0)
 ;;=4^HEMORRHOIDS NOS
 ;;^UTILITY(U,$J,358.3,12508,2)
 ;;=^123922
 ;;^UTILITY(U,$J,358.3,12509,0)
 ;;=607.84^^77^780^7
 ;;^UTILITY(U,$J,358.3,12509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12509,1,3,0)
 ;;=3^607.84
 ;;^UTILITY(U,$J,358.3,12509,1,4,0)
 ;;=4^IMPOTENCE, ORGANIC ORIGN
 ;;^UTILITY(U,$J,358.3,12509,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,12510,0)
 ;;=592.0^^77^780^8
 ;;^UTILITY(U,$J,358.3,12510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12510,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,12510,1,4,0)
 ;;=4^KIDNEY STONES
 ;;^UTILITY(U,$J,358.3,12510,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,12511,0)
 ;;=185.^^77^780^11
 ;;^UTILITY(U,$J,358.3,12511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12511,1,3,0)
 ;;=3^185.
 ;;^UTILITY(U,$J,358.3,12511,1,4,0)
 ;;=4^PROSTATE, MALIGN NEOPLASM
 ;;^UTILITY(U,$J,358.3,12511,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,12512,0)
 ;;=599.0^^77^780^12
 ;;^UTILITY(U,$J,358.3,12512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12512,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,12512,1,4,0)
 ;;=4^URINARY TRACT INFECTION
 ;;^UTILITY(U,$J,358.3,12512,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,12513,0)
 ;;=V10.46^^77^780^6
 ;;^UTILITY(U,$J,358.3,12513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12513,1,3,0)
 ;;=3^V10.46
 ;;^UTILITY(U,$J,358.3,12513,1,4,0)
 ;;=4^HX-PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,12513,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,12514,0)
 ;;=600.3^^77^780^5
 ;;^UTILITY(U,$J,358.3,12514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12514,1,3,0)
 ;;=3^600.3
 ;;^UTILITY(U,$J,358.3,12514,1,4,0)
 ;;=4^CYST OF PROSTATE
 ;;^UTILITY(U,$J,358.3,12514,2)
 ;;=^322241
 ;;^UTILITY(U,$J,358.3,12515,0)
 ;;=600.00^^77^780^2
 ;;^UTILITY(U,$J,358.3,12515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12515,1,3,0)
 ;;=3^600.00
 ;;^UTILITY(U,$J,358.3,12515,1,4,0)
 ;;=4^BPH W/O URINARY OBSTRUCT
 ;;^UTILITY(U,$J,358.3,12515,2)
 ;;=^329932
 ;;^UTILITY(U,$J,358.3,12516,0)
 ;;=600.01^^77^780^1
 ;;^UTILITY(U,$J,358.3,12516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12516,1,3,0)
 ;;=3^600.01
 ;;^UTILITY(U,$J,358.3,12516,1,4,0)
 ;;=4^BPH W URINARY OBSTRUCTN
 ;;^UTILITY(U,$J,358.3,12516,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,12517,0)
 ;;=600.10^^77^780^10
 ;;^UTILITY(U,$J,358.3,12517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12517,1,3,0)
 ;;=3^600.10
 ;;^UTILITY(U,$J,358.3,12517,1,4,0)
 ;;=4^NOD PROSTATE W/O UR OBST
 ;;^UTILITY(U,$J,358.3,12517,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,12518,0)
 ;;=600.11^^77^780^9
 ;;^UTILITY(U,$J,358.3,12518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12518,1,3,0)
 ;;=3^600.11
 ;;^UTILITY(U,$J,358.3,12518,1,4,0)
 ;;=4^NOD PROSTATE W UR OBST
 ;;^UTILITY(U,$J,358.3,12518,2)
 ;;=^329935
 ;;^UTILITY(U,$J,358.3,12519,0)
 ;;=600.20^^77^780^4
 ;;^UTILITY(U,$J,358.3,12519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12519,1,3,0)
 ;;=3^600.20
 ;;^UTILITY(U,$J,358.3,12519,1,4,0)
 ;;=4^BPH-LOCALZED W/O UR OBST
 ;;^UTILITY(U,$J,358.3,12519,2)
 ;;=^329936
 ;;^UTILITY(U,$J,358.3,12520,0)
 ;;=600.21^^77^780^3
 ;;^UTILITY(U,$J,358.3,12520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12520,1,3,0)
 ;;=3^600.21
 ;;^UTILITY(U,$J,358.3,12520,1,4,0)
 ;;=4^BPH-LOCALIZED W UR OBST
 ;;^UTILITY(U,$J,358.3,12520,2)
 ;;=^329937
 ;;^UTILITY(U,$J,358.3,12521,0)
 ;;=788.99^^77^780^13
 ;;^UTILITY(U,$J,358.3,12521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12521,1,3,0)
 ;;=3^788.99
 ;;^UTILITY(U,$J,358.3,12521,1,4,0)
 ;;=4^URINARY TRACT SYMPTOMS
 ;;^UTILITY(U,$J,358.3,12521,2)
 ;;=^273391
 ;;^UTILITY(U,$J,358.3,12522,0)
 ;;=274.9^^77^781^3
 ;;^UTILITY(U,$J,358.3,12522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12522,1,3,0)
 ;;=3^274.9
 ;;^UTILITY(U,$J,358.3,12522,1,4,0)
 ;;=4^GOUT
 ;;^UTILITY(U,$J,358.3,12522,2)
 ;;=^52625
 ;;^UTILITY(U,$J,358.3,12523,0)
 ;;=724.2^^77^781^4
 ;;^UTILITY(U,$J,358.3,12523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12523,1,3,0)
 ;;=3^724.2
